Eric Aria Fernandez, PhD

Eric Aria Fernandez, PhD is a Product Manager II at NalaGenetics, where Eric Aria launched the first comprehensive breast cancer risk prediction genetic test in Indonesia. Eric Aria has also managed multiple research projects and developed new Nala Risk Prediction indications. Prior to this, Eric worked as a Postgraduate Research Associate at the University of Lausanne, where Eric Aria managed a multimillion funded research project. Eric Aria also served as a Senior Intern at The Alignment Initiative and an International Student Ambassador at Queen's University Belfast. Eric holds a PhD in Genome Sciences/Genomics, a Master of Research in Translational Medicine, a Bachelor of Pharmacy in Clinical and Community Pharmacy, and an Apothecary degree.